582 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Planning Directions Inc.

Planning Directions Inc. acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 582 shares of the company’s stock, valued at approximately $236,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. CreativeOne Wealth LLC acquired a new stake in HCA Healthcare during the 1st quarter valued at $231,000. Bessemer Group Inc. raised its stake in HCA Healthcare by 51.2% in the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after purchasing an additional 2,584 shares during the last quarter. Swedbank AB purchased a new stake in shares of HCA Healthcare during the first quarter worth about $95,882,000. EP Wealth Advisors LLC boosted its position in HCA Healthcare by 1.6% during the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock worth $72,335,000 after acquiring an additional 3,516 shares during the last quarter. Finally, AustralianSuper Pty Ltd raised its holdings in HCA Healthcare by 118.5% in the 3rd quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company’s stock valued at $14,425,000 after acquiring an additional 19,247 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.7 %

HCA stock opened at $342.96 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $238.82 and a fifty-two week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock has a market cap of $86.87 billion, a PE ratio of 15.40, a price-to-earnings-growth ratio of 1.32 and a beta of 1.68. The firm’s 50-day simple moving average is $385.11 and its 200 day simple moving average is $357.92.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.77%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Royal Bank of Canada increased their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. KeyCorp cut their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Finally, StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.